Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

SELL
$63.71 - $70.74 $637 - $707
-10 Reduced 58.82%
7 $0
Q1 2023

Apr 10, 2023

SELL
$65.71 - $74.53 $854 - $968
-13 Reduced 43.33%
17 $1,000
Q4 2022

Jan 23, 2023

BUY
$68.48 - $81.09 $890 - $1,054
13 Added 76.47%
30 $0
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $2 - $1,306
17 New
17 $1,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Level Financial Advisors, Inc. Portfolio

Follow Level Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Level Financial Advisors, Inc. with notifications on news.